Concord Grape Juice, cognitive function and driving performance: a 12 week, placebo controlled, randomised, crossover trial in mothers of pre-teen children by Lamport, Daniel et al.
1 
 
 
 
Concord Grape Juice, cognitive function and driving performance: a 12 week, placebo 1 
controlled, randomised, crossover trial in mothers of pre-teen children 2 
Daniel J Lamport, Clare L Lawton, Natasha Merat, Hamish Jamson, Kyriaki Myrissa, Denise 3 
Hofman, Helen K Chadwick, Frits Quadt, JoLynne D Wightman, Louise Dye 4 
School of Psychology, University of Leeds, UK (DL, CL, KM, DH, HC, LD) 5 
Institute for Transport Studies, University of Leeds, UK (NM, HJ) 6 
Quadt Consultancy B.V., Schiedam, The Netherlands (FQ) 7 
Welch Foods Inc. Concord, MA, USA. (JW) 8 
Corresponding author: Professor Louise Dye 9 
email: l.dye@leeds.ac.uk, phone: +44 113 3435707 10 
Reprints will not be available from the author 11 
This research was funded by Welch Foods Inc. Concord, MA, USA 12 
Running head: Grape juice and cognitive function: an RCT 13 
Clinicaltrials.gov identifier: NCT01411631  14 
Abbreviations: CGJ Concord grape juice; MCI mild cognitive impairment; CREB cAMP-15 
response element-binding protein; BDNF brain derived neurotrophic factor; VVLT Visual 16 
Verbal Learning Test; VSLT Visual Spatial Learning Test; RVIP Rapid Visual Information 17 
Processing; TOH Tower of Hanoi; SDLP standard deviation of lane position; TtLC time to 18 
line crossing; STREV steering reversal rate; HFS high frequency component of steering      19 
Names for PubMed indexing: Lamport, Lawton, Merat, Jamson, Myrissa, Hofman, 20 
Chadwick, Quadt, Wightman, Dye  21 
2 
 
 
 
Abstract 22 
Background: Daily consumption of Concord grape juice (CGJ) over three to four months has 23 
been shown to improve memory function in adults with mild cognitive impairment, and 24 
reduce blood pressure in hypertensive adults. These benefits are likely due to the high 25 
concentration of polyphenols in CGJ. Increased stress can impair cognitive function and 26 
elevate blood pressure.  Thus we examined the potential beneficial effect of CGJ in 27 
individuals experiencing somewhat stressful demanding lifestyles.  28 
Objective: To examine the effects of twelve weeks’ daily consumption of CGJ on cognitive 29 
function, driving performance, and blood pressure in healthy, middle-aged working mothers. 30 
Design: Twenty five healthy mothers of pre-teen children, aged 40-50 years, who were 31 
employed for > 30 hours/week consumed 12oz (355ml) CGJ (containing 777mg total 32 
polyphenols) or an energy, taste and appearance matched placebo daily for twelve weeks 33 
according to a randomised, crossover design with a four week washout. Verbal and spatial 34 
memory, executive function, attention, blood pressure and mood were assessed at baseline, 35 
six weeks and twelve weeks. Immediately following the cognitive battery, a subsample of 36 
seventeen females completed a driving performance assessment in the University of Leeds 37 
Driving Simulator. The twenty five minute driving task required participants to match the 38 
speed and direction of a lead vehicle.  39 
Results: Significant improvements in immediate spatial memory and driving performance 40 
were observed following CGJ relative to placebo. There was evidence of an enduring effect 41 
of CGJ such that participants who received CGJ in arm 1 maintained better performance in 42 
the placebo arm.  43 
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Conclusions: Cognitive benefits associated with chronic consumption of flavonoid-rich grape 44 
juice are not exclusive to adults with mild cognitive impairment. Moreover, these cognitive 45 
benefits are apparent in complex everyday tasks such as driving. Effects may persist beyond 46 
cessation of flavonoid consumption and future studies should carefully consider the length of 47 
washout within crossover designs.   48 
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Introduction 49 
Recent reviews have suggested consumption of polyphenol-rich foods and drinks such as 50 
grape juice, blueberries and cocoa are associated with cognitive benefits in humans [1]. 51 
Concord grape juice (CGJ) is a rich source of polyphenols, particularly flavonoids such as 52 
proanthocyanidins and anthocyanins, which have been postulated to positively affect 53 
cognitive function by a variety of mechanisms including inhibition of neuroinflammation [2] 54 
and inducing neurogenesis and synaptic plasticity [3]. Improved verbal learning and reduced 55 
semantic interference on memory tasks in older adults with mild cognitive impairment (MCI) 56 
were reported following daily consumption of CGJ for twelve weeks [4] and sixteen weeks 57 
[5]. Evidence for underlying mechanisms comes from blueberry supplementation studies in 58 
aged rats, where increased activation of cAMP-response element-binding protein (CREB), 59 
increased hippocampal levels of brain derived neurotrophic factor (BDNF) and an 60 
accompanying benefit to spatial working memory were observed following three to twelve 61 
weeks of supplementation [6]. Enhanced vascular physiology in the brain such as improved 62 
cerebral blood flow has been observed in humans following consumption of cocoa flavanols 63 
[7,8]. It is proposed that such effects are mediated by enhanced endothelial function and 64 
increased bioavailability of nitric oxide [9,10]. Increased activation in the right middle 65 
prefrontal and right superior parietal cortical regions using fMRI (functional magnetic 66 
resonance imaging) was observed in adults with MCI following CGJ consumption enhanced 67 
cerebral blood flow. Endothelial and nitric oxide pathways are implicated in the beneficial 68 
effects on cardiovascular outcomes induced by CGJ and other polyphenol rich foods and 69 
drinks [11,12].  70 
The allostatic load model describes how chronic stress, CVD and associated risk factors can 71 
lead to a cascade of physiological and psychological consequences, such as cognitive 72 
impairment [13-15]. Individuals experiencing elevated levels of daily stress may, therefore, 73 
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be particularly responsive to the benefits of consuming polyphenol-rich foods and drinks such 74 
as CGJ, as supported by animal models [16]. We recruited a healthy cohort who reported 75 
experiencing a psychologically demanding and potentially stressful lifestyle, and thus might 76 
benefit from chronic polyphenol consumption; working mothers with pre-teen children. 77 
Whilst it is important to consider effects on specific cognitive domains reflecting particular 78 
neurological processes, the ecological validity; i.e. extent to which performance on a battery 79 
of cognitive tests is related to everyday cognitive tasks is also important [17]. Driving is a 80 
highly ecological behaviour requiring a multitude of complex processes encompassing all 81 
cognitive domains. Psychologically stressed individuals are more vulnerable to driving errors 82 
due to an overload of attentional resources [18]. It is, therefore, of interest to examine 83 
whether dietary polyphenol based interventions can affect performance on everyday tasks 84 
such as driving, which can be assessed in a controlled laboratory environment. This study 85 
examined performance on several cognitive domains shown to be sensitive to berry 86 
polyphenol consumption [1], in addition to longitudinal and lateral tracking tasks within an 87 
immersive driving environment using a state of the art driving simulator.  88 
Subjects and Methods 89 
Design 90 
Concord grape juice (CGJ) or a placebo were consumed daily for twelve weeks according to 91 
a double-blind randomised crossover design. Previous data indicate that twelve weeks daily 92 
consumption of CGJ is a sufficient duration to detect cognitive benefits [4]. Participants were 93 
assigned to one of two orders (CGJ then placebo, or placebo then CGJ) according to a 94 
counterbalanced randomisation schedule prepared by an independent statistician. Outcome 95 
variables were assessed at three time points per arm: baseline (prior to drink consumption), 96 
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six weeks (post daily consumption) and twelve weeks (post daily consumption). Each arm 97 
was separated by a four week washout.  98 
Treatment Drinks 99 
The 12oz (355ml) daily servings of CGJ and placebo were matched for energy (233kcal), 100 
appearance, taste, volume (355mls), and carbohydrate content (59.5g) and all sugars (54g). 101 
The CGJ contained 777mg total polyphenolics as gallic acid equivalent per 355ml daily 102 
serving (167mg anthocyanins as malvidin equivalent and 334mg proanthocyanidins as 103 
catechin equivalent). No vitamin C was present in either CGJ or placebo. Total polyphenol 104 
concentration was determined by the Folin-Ciocalteu procedure [19]. Anthocyanins were 105 
determined by a spectrophotometric procedure [20]. Proanthocyanidins were determined by 106 
normal-phase, high-performance liquid chromatography after solid-phase extraction of the 107 
juice with a Sephadex LH-20 [21,22]. The daily dosage was selected upon evaluation of 108 
previous research showing that a 12oz (355ml) daily dose of CGJ containing 740mg total 109 
polyphenolics over twelve weeks is sufficient to detect cognitive benefits [4]. Both drinks 110 
were analysed and prepared by Welch Foods Inc, USA and refrigerated at between 1-5oC 111 
until distributed to participants who were instructed to keep the juice refrigerated. To ensure 112 
double-blinding the CGJ and placebo were labelled with a three letter code by Welch Foods 113 
Inc. The code was revealed to the experimenters on completion of the analysis. Both drinks 114 
underwent standard microbiological and safety testing by Welch Foods Inc. To examine 115 
equivalence of taste participants responded to the following question “How pleasant did you 116 
find the drink” on a 10cm Likert scale after consuming the drink at each visit.  117 
Participants 118 
Twenty five working female mothers were recruited from Leeds (UK) and the surrounding 119 
area. The inclusion criteria were ; 40-50 years of age, at least one child younger than 13 years 120 
7 
 
 
 
of age, BMI 18-29kg/m2, employment > 30 hours per week, adequate understanding of verbal 121 
and written English, possession of a full driving licence for >5 years, having driven >5000 122 
miles in the past year. Exclusion criteria were smoking, self-reported menopausal symptoms, 123 
working night shifts, pregnant or planning pregnancy in the next six months, consuming > 124 
three portions of fruit/vegetables per day, vegetarian, current or history of eating disorder 125 
(>20 EAT-26) [23], and any current illness or disease. The following additional exclusion 126 
criteria were required for the driving performance subsample: epilepsy, claustrophobia, fear 127 
of heights and severe motion sickness.  All eligible participants completed a screening test 128 
drive in the driving simulator and were familiarised with the cognitive test battery and other 129 
measures before randomisation. This required completion of a full version of the cognitive 130 
battery. Twenty five participants started arm one. Two participants withdrew after completing 131 
the first arm (n=2, both completed the placebo arm) neither of whom gave a reason for 132 
withdrawal. A further four withdrew during the second arm (n=3 CGJ and n=1 placebo). Of 133 
these four withdrawals, one reported depression (CGJ), and three reported they no longer 134 
wanted to drink the juice. Therefore, twenty five participants completed the first arm and 135 
nineteen participants completed both arms. Of the twenty five initial recruits, seventeen met 136 
the driving simulator inclusion/exclusion criteria. Cognitive performance was the primary 137 
outcome measure, and therefore, participants who failed the driving simulator screening were 138 
retained and data were collected for all other outcome measures. Of the seventeen 139 
participants who passed the driving simulator screening, one participant was excluded for 140 
non-compliance with the driving task. Of the remaining sixteen participants, driving 141 
performance data for both arms were available for eleven participants (since, as described 142 
above, five participants withdrew during arm two). Participant characteristics at screening are 143 
show in Table 1.  144 
[Table 1 here] 145 
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Cognitive Function 146 
The 45 minute cognitive test battery comprised of seven tests administered in the following 147 
order; Visual Verbal Learning Test (VVLT) immediate recall (verbal memory), Visual 148 
Spatial Learning Test (VSLT) immediate recall (non-verbal, spatial memory), Rapid Visual 149 
Information Processing (RVIP) (executive function), Grooved Peg Board (psychomotor 150 
skill), Tower of Hanoi (TOH) (executive function), VVLT delayed recall and VSLT delayed 151 
recall. Equivalent versions of each test were incorporated in a counterbalanced order across 152 
the six cognitive test sessions, whilst the order in which the tests occurred within the 153 
cognitive test battery remained constant across all administrations.   154 
The Visual Verbal Learning Test (VVLT) is a visual analogue of the Rey Auditory-Verbal 155 
Learning Test [24]. Three trials of sixteen words (List A) were presented in a random 156 
sequence on a computer screen at the rate of one word every two seconds. At the end of each 157 
trial, participants were instructed to verbally recall as many of the words as possible in a free 158 
recall task over one minute (trials A1, A2 & A3). Trial A3 was followed by presentation of a 159 
sixteen word interference list (List B) and a subsequent free recall of these words over one 160 
minute (trial B1). A one minute free recall of List A without presentation immediately 161 
succeeded this (trial A4). Outcome variables were the mean number of words recalled over 162 
trials A1-A3, retroactive interference (A3-A4) and proactive interference (A1-B1). Delayed 163 
memory was assessed thirty minutes after the initial presentation of the test.  164 
The Visual Spatial Learning Test (VSLT) [25] is a test of visuospatial memory and learning. 165 
The original version of the test was designed as an assessment of dementia and involves five 166 
trials. However, to avoid ceiling effects in the present sample without dementia only three 167 
trials were administered. At each identical trial participants were given ten seconds to observe 168 
the image and location of seven abstract patterns placed on 5x4 grid. The task was to 169 
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correctly choose the seven target patterns from a choice of fifteen and place them on the 170 
correct locations on the grid. The outcome variable was the number of correct targets placed 171 
in the correct location per trial (maximum 7). Delayed VSLT performance was assessed thirty 172 
minutes after initial presentation of the test.  173 
The RVIP involved presentation of a series of single digits at a rate of 600 milliseconds with 174 
a 600 millisecond inter-stimulus interval. The task lasted for six minutes with 100 stimuli per 175 
one minute block and five odd and five even targets within each block. Target sequences 176 
were three consecutively presented odd or even numbers which required participants to press 177 
the space bar as quickly as possible. Outcome variables were the number of correctly 178 
identified sequences, the number of false positive responses and reaction time for correct 179 
responses.  180 
The Grooved Peg Board [26] assesses manual dexterity and is a test of psychomotor skill. 181 
The apparatus consisted of a board with 25 holes and 35 identical pegs. The pegs had a 182 
groove down one side. The holes were to be filled with pegs in a specified order as quickly as 183 
possible. Participants completed the task with their dominant hand followed by their non-184 
dominant hand. The outcome variable was completion time to fill the board with pegs 185 
(averaged across both hands).  186 
The Tower of Hanoi [27] is a test of planning ability which is considered an exemplar 187 
measure of executive function. A computerised version was administered. This consisted of a 188 
visual representation of three rods upon which four discs of different size and colour were 189 
placed. At the top of the screen was the target formation of discs on the rods and at the 190 
bottom of the screen was the starting formation. The aim of the task was to rearrange the 191 
disks on the starting formation rods to match the target formation in the fewest possible 192 
moves. There was only one correct sequence of moves for each trial. This was the fewest 193 
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number of moves required to match the target formation. If the participant deviated from the 194 
correct sequence the screen refreshed to the original starting formation. There was one rule: a 195 
disk could not be placed on a disk which was larger than itself, such moves were not recorded 196 
as errors as the computer would not allow it. At the outset, the screen informed the participant 197 
of the number of moves required to complete a trial. There were ten trials per test 198 
administration, consisting of two trials for each of the five levels of 4,5,6,7 and 8 moves. 199 
Level 4 trials consisted of a sequence of four blocks, level 5 consisted of a sequence of five 200 
blocks, and so on. There were two outcome variables: (i) number of errors made, and (ii) 201 
completion time.  202 
Blood pressure and subjective mood 203 
Resting systolic and diastolic blood pressure were measured with an ambulatory blood 204 
pressure monitor (Omron M7). Measurements were taken following 15 minutes rest on the 205 
left upper arm, and the average of three consecutive measurements was calculated. Subjective 206 
mood was assessed using pen and paper 100mm Visual Analogue Scales (VAS) with 207 
questions relating to hunger, fullness, contentedness, irritability, sleepiness, mental alertness, 208 
ability to concentrate, and energy with anchors for each adjective; “not at all” and “very”. 209 
Subjective stress was assessed with the Perceived Stress Scale (PSS) and state anxiety was 210 
assessed using the short 6-item form (MSTAIY6) [28] of the State Trait Anxiety Inventory 211 
[29].  212 
Driving Performance 213 
A twenty five minute virtual driving scenario of car following and lane keeping was 214 
choreographed within the University of Leeds Advanced Driving Simulator. The high fidelity 215 
simulator consists of a Jaguar S-type vehicle, a 4m diameter spherical projection dome which 216 
houses an eleven channel display system covering a forward field of view of 270° and a large 217 
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amplitude, eight degree-of-freedom electrical motion system with five meters of effective 218 
travel in surge and sway. Driving performance was assessed by two tasks; (i) a longitudinal 219 
task (car following) and (ii) a lateral task (lane keeping). The longitudinal and lateral tasks 220 
were performed concurrently.  221 
The longitudinal task required participants to “follow a lead vehicle at a safe and constant 222 
distance gap”. The lead vehicle adjusted its speed in a smooth fashion matching a 60 second 223 
period sine wave with a maximum speed of 60mph and a minimum speed of 40mph until five 224 
cycles of the sine wave were completed (a driving distance of approximately seven km). The 225 
drive consisted of sections of straight and curved road. The curved sections were alternate 226 
bends to the left and right with a radius of 750 meters and a length of 252 meters. There were 227 
three independent variables for the longitudinal task; coherence, phase shift and modulus 228 
[30]. Coherence, a measure of correlation of the two speed cycles, indicates the accuracy of 229 
the participant's speed adjustments in order to meet the main longitudinal tracking task 230 
requirement to maintain a consistent following distance. Coherence can range from zero (no 231 
coherence between the two cycles) to one (perfect coherence). Phase shift measures the delay 232 
between the change in the lead vehicle’s speed and the subsequent response (akin to a delay 233 
in response). Modulus is an amplification factor between the two signals, expressed as the 234 
amplitude gain; if the participant overreacts to the lead vehicle’s speed changes, the modulus 235 
will be larger than one. Data was analysed for the final four of the five, five minute sine wave 236 
cycle; the first cycle allowed the participant time to settle into the task.  237 
The lateral task required participants to maintain a constant position in the driving lane. There 238 
were four outcome measures for the lateral task; standard deviation of lane position (SDLP), 239 
time to line crossing (TtLC), steering reversal rate (STREV) and high frequency component 240 
of steering (HFS). The SDLP measured the variation in lane position. TtLC was defined as 241 
the time to cross either lane boundary with any of the wheels of the vehicle. Therefore, as the 242 
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vehicle approached the edge of the road, TtLC decreased. A TtLC <2 seconds was the 243 
threshold for close proximity to exiting the lane boundary [31]. A TtLC < 2 seconds is termed 244 
TETtLC2. The total time exposure during which TETtLC2 occurred was measured. 245 
Therefore, TETtLC2 defined the duration for which the participant was driving in close 246 
proximity to the lane boundary. STREV was the number of changes in steering wheel 247 
direction per minute (an angle of 1o is required to qualify as a reversal). A higher STREV 248 
indicated higher difficulty in achieving accurate tracking. HFS reflected the number of 249 
steering corrections. Increased corrections were indicative of erratic, reactive driving as 250 
opposed to having a strong awareness of the road ahead which is associated with predictive 251 
steering and fewer corrections [32].      252 
Procedure 253 
Inclusion and exclusion criteria were checked at a screening session which took place at the 254 
University of Leeds, Human Appetite Research Unit (as did all test days and procedures 255 
notwithstanding the driving simulator procedures which took place at the University of Leeds 256 
Advanced Driving Simulator). Screening included a recruitment information questionnaire 257 
(assessing general health), a measure of eating behaviour (EAT-26) the National Adult 258 
Reading Test (NART) [33], baseline PSS, a measure of hostility (Cook-Medley Hostility 259 
Scale) [34], and a measure of baseline trait anxiety (Spielberger State-Trait Anxiety 260 
Inventory, STAIY2 [29]. Height, weight and blood pressure were measured and 261 
familiarisation versions of the cognitive battery and driving performance task were 262 
completed. Participants were informed that consumption of the following polyphenol-rich 263 
drinks were not permitted for the duration of the study, including the four week washout; red 264 
wine, grape juice (notwithstanding the treatment drink), or any dark fruit juices. A minimum 265 
of one week separated the screening visit and test day 1. The day before each test day, 266 
participants refrained from exercise and alcohol consumption after 17:00 hours, and were told 267 
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to consume an evening meal of their choice before 21:00 hours. The meal was standardised 268 
across all test days (within participants) to control for second meal cognitive effects [35]. All 269 
test days commenced between 07:30 and 10:00 hours with participants fasted (except water) 270 
from 21:00 hours. Data were collected in the following order; weight, mood #1 (VAS), stress 271 
(PSS), anxiety (MSTAIY6) and blood pressure. The treatment drink was then consumed 272 
within fifteen minutes followed by mood #2 and commencement of the cognitive battery. 273 
Mood#3 was assessed upon completion of the cognitive battery and participants were 274 
escorted to the Institute for Transport Studies to commence the driving performance task. 275 
Immediately prior to and after the driving task mood #4 and #5 were assessed. The total time 276 
for the test day was approximately two hours. To monitor compliance, participants were 277 
required to return bottle tops from the consumed drinks to the Human Appetite Research Unit 278 
on a weekly basis and to complete a daily drink diary detailing time of consumption. 279 
Compliance was high; 22 participants reported 100% compliance, and all participants except 280 
one exceeded 90% compliance (at least 75 days recorded). The lowest compliance was 76% 281 
(64/84 days recorded). Participants received a £160 honorarium upon completion of the 282 
study, or pro rata for withdrawals. The School of Psychology Research Ethics Committee 283 
reviewed the procedures and awarded a favourable opinion for conduct. Recruitment 284 
commenced in January 2011 with the last participant completing in June 2012.                 285 
Statistical Analysis 286 
Analysis was performed by an independent statistician. An intention to treat (ITT) analysis 287 
was performed which included data for all participants who completed the first arm (n=25 for 288 
cognitive performance, and n=16 for driving performance). Within-subjects ANCOVAs were 289 
performed to examine the effects of Condition (CGJ/placebo) and Visit (day 1 (baseline), 6 290 
weeks, 12 weeks) nested within Study Phase (arm 1/arm 2) on all outcome variables. 291 
Covariates were age, IQ (NART), subjective stress (PSS), psychological hostility (Cook-292 
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Medley Hostility Scale), state anxiety (STAIY2) and eating behaviour (EAT-26), all of which 293 
were assessed at screening (see procedure).  294 
All main effects and their interactions were requested in the first model and all covariates 295 
were included. Non-significant interactions with covariates were removed first and the 296 
analysis was re-run. Next, non-significant covariates were removed, then higher order 297 
interactions of fixed factors. The resulting model was compared to the previous model using 298 
the McQuarrie Tsai AICc criterion [36]. The AICc criterion gives an indication of the amount 299 
of remaining unexplained variance after the model has been fitted, where a smaller AICc 300 
value indicates a better model. If an improvement in model fit was found, other non-301 
significant effects were removed and again the AICc criterion used to evaluate the model fit. 302 
Models were chosen on the basis of ‘best fit’, and interaction terms that improved the fit were 303 
retained. The reported ANCOVAs are the ‘best fit’ (i.e. lowest AICc) models adjusted for 304 
significant covariates. Tukey-Kramer post hoc tests were employed to follow-up significant 305 
main effects or interactions and the p-values reported are adjusted for multiple comparisons. 306 
Analyses were performed with SAS® v9.3 and all residuals were screened and outliers were 307 
removed.  308 
Results 309 
Drink Characteristics 310 
The ANCOVA for “pleasantness” data showed no significant main effects or interactions, 311 
indicating equivalence of taste. Upon completion of both arms 12/19 (63%) participants 312 
identified CGJ as the active drink, which was not significantly different to chance according 313 
to a one sample t-test (t=1.16, df=18, p=0.26).  314 
Cognitive Performance 315 
15 
 
 
 
Verbal recall 316 
VVLT immediate recall averaged over the first three trials (A1 to A3) showed a significant 317 
Condition*Study Phase interaction (F[1,20]=4.61, p<0.05). As shown in Figure 1, post hoc 318 
tests revealed that this interaction was specific to the placebo condition whereby recall was 319 
better when the placebo was consumed in arm 2 relative to arm 1 (p<0.05). This indicates an 320 
initial benefit of the CGJ in arm 1 which endured into arm 2 when the placebo was 321 
consumed. No significant effects were observed for retroactive, proactive interference, or 322 
delayed VVLT recall (see Table 2).  323 
 Spatial Recall 324 
VSLT immediate recall showed a significant main effect of Condition (F[1,22]=5.58, p<0.05) 325 
such that recall (total over 3 trials) was higher following CGJ (mean 12.72, se 0.39 relative to 326 
placebo (mean 12.57, se 0.36). Immediate and delayed VSLT recall were significantly higher 327 
in arm 2 relative to arm 1 as indicated by a main effect of Study Phase (immediate 328 
F[1,21]=12.8, p<0.01; delayed F[1,17]=5.24, p<0.05). 329 
Psychomotor skill 330 
Completion time for the Pegboard showed a significant Condition*Study Phase interaction 331 
(F[1,21]=9.61, p<0.01). Post hoc tests revealed that in arm 1, completion time was 332 
significantly faster for the placebo (mean 60.4 secs se 1.9) relative to CGJ (mean 63.2 se 2.3) 333 
(p<0.05) whereas no difference was observed between the two drink conditions in arm 2.  334 
Executive function 335 
ToH completion time showed a significant Condition*Study Phase interaction 336 
(F[1,21]=14.12, p<0.01). As shown in Figure 2, post hoc tests revealed that completion time 337 
was significantly faster for the CGJ relative to the placebo in arm 1 (p<0.01) whereas this 338 
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difference was not significant in arm 2. A main effect of Study Phase was observed for the 339 
number of errors (F[1,21]=5.27, p<0.05) such that fewer errors were made in arm 2 (mean 340 
3.6 se 0.6) relative to arm 1 (mean 6 se 1.1). No significant effects were observed for reaction 341 
time, correctly identified targets or false positives on the RVIP (see Table 2).  342 
[Figures 1 & 2 here] 343 
Driving Performance 344 
Longitudinal tracking task (car following)  345 
Analysis of coherence revealed that the main effect of Condition was significant 346 
(F[1,11]=4.64, p=0.05) such that car following was more accurate during CGJ (mean 0.97 se 347 
0.01) relative to placebo (mean 0.96 se 0.01). Similarly, the main effect of Condition 348 
approached significance for phase shift analysis (F[1,11]=4.26, p=0.06) such that CGJ was 349 
associated with a quicker driver response to changes in the lead vehicle speed (CGJ mean 350 
3.54 se 0.54; placebo mean 4.13 se 0.64). Finally, analysis of modulus revealed a main effect 351 
of Study Phase (F[1,10]=6.67, p<0.05) such that performance was better (less overshoot) in 352 
arm 1 (mean=1.1 se 0.03) relative to arm 2 (mean 1.14 se 0.03).  353 
Lateral tracking 354 
A significant Condition*Study Phase interaction was observed for steering reversals 355 
(F[1,10]=16.73, p<0.01) such that during arm 1 steering control was more stable (fewer 356 
steering reversals) for the CGJ condition, whereas at arm 2 steering control was more stable 357 
for the placebo condition (although post hoc tests did not reach significance; see Figure 3). 358 
No significant effects were observed for time to line crossing (TETtLC2), lane position 359 
(SDLP) or for high frequency component of steering (HFS). 360 
[Figure 3 here] 361 
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Subjective Outcomes & Blood Pressure  362 
Contentedness was significantly higher in arm 1 (mean 64 se 2.6) relative to arm 2 (mean 60 363 
se 2.5) as indicated by a main effect of Study Phase (F[1,21]=5.35 p<0.05). Alertness and 364 
concentration were significantly higher for participants who consumed CGJ in arm 1; mean 365 
58 and 60 respectively (se 3.6 and 3.7), relative to participants who consumed CGJ in arm 2; 366 
mean 53 and 56 respectively (se 3.4 and 3.3) (both p<0.05) as indicated by significant 367 
Condition*Study Phase interactions (F[1,21]=19.45, p<0.001 & F[1,21]=24.98, p<0.0001 368 
respectively). A significant Condition*Study Phase interaction was also observed for stress 369 
ratings (F[1,21]=4.86, p<0.05), however, post hoc tests failed to reach significance. There 370 
were no other significant effects of interest for the subjective mood outcomes. There were no 371 
significant effects for either diastolic or systolic blood pressure (see Table 2).  372 
[Table 2 here] 373 
Discussion 374 
CGJ was associated with better immediate spatial memory and two aspects of driving 375 
performance in this sample of healthy working mothers of pre-teen children aged 40-50 376 
years, relative to a placebo. Previous interventions demonstrating benefits of CGJ have been 377 
performed exclusively in older adults with mild cognitive impairment [4,5], thus this is the 378 
first study to demonstrate cognitive benefits following CGJ in healthy middle-aged adults. 379 
These results in combination with another recent study showing executive function and 380 
memory improvements following consumption of flavanone-rich orange juice [37] indicate 381 
cognitive benefits achieved from regular daily flavonoid consumption are not exclusive to 382 
adults exhibiting cognitive decline or neurodegenerative disease. Moreover, long term-383 
consumption of CGJ was associated with reduced phase shift in car following, comparable to 384 
quicker reaction time to unfolding traffic events. This was evidenced by increased steering 385 
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accuracy in combination with a faster response time to changes in lead vehicle behaviour 386 
during car following. The observed effects would account for a reduction in stopping distance 387 
of approximately eleven meters at the speeds driven (40-60mph), which is a significant safety 388 
benefit. Thus, the cognitive effects of chronic CGJ consumption translate into meaningful 389 
outcomes on everyday tasks.  390 
The observed subtle benefit for spatial memory is consistent with rodent literature [6,38] and 391 
several other polyphenol interventions in humans. It has been proposed that memory function 392 
is particularly susceptible to potential mechanisms which underlie the association between 393 
flavonoids and cognitive benefits [3], possibly because the hippocampus is a region where 394 
flavonoids and their metabolites seem able to exert their actions [6,38]. In support, improved 395 
performance of a spatial recognition task and increased activation using fMRI was seen in the 396 
dentate gyrus (a sub-region of the hippocampus) in healthy older adults following 3 months 397 
consumption of flavanol-rich cocoa [7].  398 
The consistent interaction between drink condition and study phase in this study over a 399 
number of cognitive outcomes, suggests enduring effects of CGJ following cessation of 400 
consumption. Specifically, benefits for verbal recall, executive function and lateral tracking 401 
associated with CGJ consumption in arm one persisted into the second arm when the placebo 402 
was consumed. Similar enduring effects were recently reported following eight week 403 
consumption of flavanone-rich orange juice after a four week washout on tests of executive 404 
function and memory [37]. These enduring effects may signify that polyphenols cause 405 
relatively stable physiological effects which do not dissipate rapidly after withdrawal from 406 
the diet. This has implications for determining a suitable washout period between treatments; 407 
4 weeks may not be sufficient in flavonoid interventions. It is also noteworthy that persistent 408 
main effects of study phase revealed performance was significantly better at the second arm 409 
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regardless of the drink consumed (e.g. immediate and delayed spatial memory, executive 410 
function). This is indicative of practice effects whereby participants improved over time. 411 
Given that cognitive benefits in healthy populations are likely to be small [17], it is crucial 412 
that potential practice effects are considered by including study phase and drink order within 413 
statistical models examining cognitive effects of flavonoid interventions. This study phase 414 
effect was not exclusive to objective cognitive outcomes; higher ratings of alertness and 415 
concentration were reported during the first arm relative to the second arm (albeit only for the 416 
CGJ condition). It is perhaps not surprising that the alertness and conscientiousness of 417 
participants may decline over the course of a twenty eight week trial, and it is entirely 418 
possible that these subjective effects have an impact upon cognitive performance [39]. This 419 
further emphasises the importance of considering order effects in chronic interventions. 420 
Previous studies which reported strong effects of CGJ on immediate verbal memory [4] and 421 
spatial recognition [5] adopted a parallel groups design where order effects are avoided.  422 
The present data show that grape flavonoids may improve performance on everyday tasks; 423 
safer driving behaviour was observed following the CGJ relative to the placebo as indicated 424 
by characteristics such as a faster response to the lead vehicle. The potential for flavonoid-425 
rich diets to have a small but significant impact on cognitive tasks such as driving should not 426 
be overlooked, and future research should consider effects on other ecologically valid every-427 
day tasks throughout the lifespan. Acute benefits of flavonoid consumption for the peripheral 428 
vascular system in the immediate postprandial period are well documented [10]. Several 429 
studies have shown improvements in endothelial function in patients with heart disease 430 
following grape juice supplementation [40,41] however, the present data did not show any 431 
chronic effects of CGJ on blood pressure. This could be a function of the population; the 432 
sample of healthy middle aged females did not have high blood pressure at the outset and 433 
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therefore the potential for a relatively short dietary intervention to have a significant impact is 434 
limited.  435 
It is important to point out that during this 28 week trial participants did not abstain from all 436 
dietary sources of anthocyanins and other polyphenols. The specific restrictions included red 437 
wine, dark fruit juice and any other grape juice. It is possible that the participants consumed 438 
other sources of polyphenols which may have masked the effectiveness of the treatment 439 
drink. However, high habitual polyphenol consumers were likely to have been captured by 440 
the exclusion criterion of >3 portions of fruits/veg per day, and it is unlikely that the habitual 441 
diets of the participants would have varied significantly between the two arms of the study. A 442 
strength of the present data is its generalisability; effects were observed regardless of any 443 
variability in habitual polyphenol intake, and in the context of the participants’ normal diets. 444 
Future studies should assess habitual intake with food diary records together with urinary 445 
measures of biomarkers and metabolites which also provide evidence of compliance to 446 
treatment. Finally, in light of the observed carry over effects, researchers should consider 447 
incorporating a suitable washout period prior to commencement of similar polyphenol 448 
interventions (and between arms), in order to reduce effects of habitual polyphenol intake, 449 
thus allowing a more sensitive assessment of the intervention. Presently, habitual dietary 450 
polyphenol intake prior to trial commencement and during the trial could account for some of 451 
the variance indicated by the Condition*Study Phase interaction for verbal recall.  452 
5. Conclusions 453 
In summary, twelve week consumption of CGJ was associated with subtle improvements in 454 
immediate spatial memory and safer driving behaviour relative to the placebo in this sample 455 
of healthy working mothers of pre-teen children aged 40-50. This is the first study to 456 
demonstrate benefits of CGJ in healthy adults on domain specific and everyday cognitive 457 
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tasks such as driving. However, it is important to acknowledge that there were no effects on 458 
the majority of cognitive outcomes. Importantly, there was evidence for enduring flavonoid 459 
effects such that when CGJ was consumed during the first arm some of the associated 460 
benefits persisted into the second arm when the placebo was consumed. In addition, practice 461 
effects were observed such that performance was generally better during the second arm, 462 
regardless of condition. The combination of the enduring effects and the practice effects may 463 
have masked some of the potential effects of the CGJ, particularly in this healthy middle-464 
aged sample in whom effects of nutritional interventions are likely to be small. These 465 
findings have clear implications for the design of future crossover interventions, and indicate 466 
that the cognitive effects of CGJ are not exclusive to older adults and adults with 467 
neurodegenerative disease. Future studies should seek to explore the strength and length of 468 
cognitive effects following cessation of flavonoid supplementation. 469 
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Table 1: Participant characteristics at baseline. Data presented are means (SE) 583 
  All participants  Participants undertaking 
the driving performance 
task 
 ITT1  
n=25 
Completed 
n=19 
ITT1 
n=16 
Completed 
n=10 
Age (yrs) 43.2 (.6) 42.8 (.7) 42.6 (.7) 42.5 (.9) 
Weight (kg) 67.5 (1.9) 68.4 (2.3) 68.8 (2.5) 72.2 (3.8) 
Height (m) 1.7 (.01) 1.7 (.02) 1.7 (.02) 1.7 (.02) 
BMI (kg/m2) 24.6 (.5) 24.4 (.5) 24.8 (.6) 25 (.7) 
Systolic BP (mmHg) 127.7 (2.1) 127.9 (2.8) 129.4 (2.6) 127.7 (2.9) 
Diastolic BP (mmHg) 82.6 (2.7) 82.6 (3.5) 86.2 (3.5) 82.6 (3.6) 
NART2 (max 50) 37.4 (1.6) 38.6 (1.7) 35.7 (2.2) 37.4 (3.1) 
Stress (PSS3) 14.9 (1) 15.3 (1.2) 14.1 (1.3) 15 (1.8) 
Cook-Medley Hostility 14.9 (1.5) 13.8 (1.8) 15.3 (2) 16.4 (2.9) 
Train Anxiety (STAI-Y2)4 41.8 (1.8) 41.5 (2.3) 41.6 (2.4) 42 (3.5) 
Eating Behaviour (EAT-
26)5 
5.1 (1.1) 5.6 (1.4) 5.2 (1.5) 5.3 (2.3) 
Pre-teen children (n) 1.6 (.2) 1.6 (.2) 1.5 (.2) 1.5 (.2) 
1Intention to treat: This includes participants who withdrew during arm two 584 
2National Adult Reading Test 585 
3Perceived Stress Scale  586 
4Spielberger State-Trait Anxiety Inventory 587 
5Eating Attitudes Test 588 
  589 
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Table 2: Scores for each cognitive test outcome, driving performance and blood pressure at each test visit by condition. Data presented are 
means (SE) 
 
Outcome Placebo 
baseline 
(n=25) 
Placebo six 
wks  
(n=24) 
Placebo 
twelve wks 
(n=24) 
CGJ 
baseline 
(n=23) 
CGJ six 
wks 
(n=23) 
CGJ twelve 
wks 
(n=20) 
Significance and 
effect observed 
(all p<0.05) 
VVLT1 immediate recall (sum A1-A3) 33.8 (1.1) 34.8 (1.3) 35.4 (1.3) 34 (1.3) 36.2 (1.2) 36.2 (1.6) Condition*Study Phase 
VVLT retroactive interference (%)2 19.9 (3.1) 13.6 (2.5) 15.9 (4.7) 12.6 (2.9) 11.6 (2.3) 15.8 (6) - 
VVLT proactive interference (%)3 8.7 (7.6) 2.6 (5.4) 13.3 (5) 3.9 (6.9) 16.6 (5.9) 18.2 (5.8) - 
VVLT delayed recall (max 16) 10.6 (0.5) 11.6 (0.5) 11.6 (0.6) 11.3 (0.6) 11.9 (0.5) 11.8 (0.7) - 
VSLT4 immediate recall (sum 3 trials) 12.4 (1.2) 12.4 (1) 13 (1.1) 11.3 (1.1) 12.2 (1.3) 14.1 (1.2) Condition 
VSLT delayed recall (max 7) 4.6 (0.4) 5.1 (0.4) 4.7 (0.5) 4.7 (0.4) 5 (0.5) 5.5 (0.4) Study Phase 
RVIP5 correct (max 60) 27.5 (2.2) 29.4 (2.7) 29 (2.4) 27.6 (2.6) 29.3 (2.4) 29.9 (2.8) - 
RVIP false positives 7.3 (1.2) 6.3 (1.6) 7.3 (1.4) 8.5 (1.6) 7.5 (1.2) 6.2 (1) - 
RVIP reaction time (ms) 458 (12) 457 (18) 452 (14) 454 (16) 459 (13) 461 (16) - 
Grooved peg board completion time (sec) 62.6 (2.3) 60 (2.1) 60.6 (2) 61.2 (2.5) 61 (2.1) 59.3 (2.1) Condition*Study Phase 
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Tower of Hanoi errors 5.6 (1.4) 5.1 (1.1) 4.5 (1) 4.4 (0.7) 5.5 (1) 4.1 (0.6) Study Phase 
Tower of Hanoi completion time (secs) 246 (22) 240 (17) 213 (11) 224 (11) 240 (25) 210 (11) Condition*Study Phase 
Driving coherence6 0.97 (0.009) 0.95 (0.011) 0.95 (0.008) 0.97 (0.009) 0.97 (0.016) 0.97 (0.013) Condition 
Driving phase shift (secs)7 4 (0.5) 4.5 (0.8) 3.9 (0.6) 3.7 (0.7) 3.6 (0.4) 3.3 (0.5) Condition (p=0.06) 
Driving modulus8 1.13 (0.04) 1.09 (0.05) 1.09 (0.04) 1.1 (0.03) 1.13 (0.02) 1.14 (0.02) Study Phase 
Driving lane position deviation9 0.19 (0.01) 0.18 (0.009) 0.18 (0.01) 0.18 (0.011) 0.19 (0.014) 0.18 (0.012) - 
Driving exposure to lane departure10 (%) 30.5 (1.1) 32.6 (1.7) 31.4 (1.1) 30.7 (1) 31.3 (1.3) 31.1 (1.5) - 
Driving steering reversals (per minute)11 26.5 (2.8) 24.9 (1.9) 25.4 (2.4) 26 (2.2) 23.8 (1.8) 26.4 (2.5) Condition*Study Phase 
Driving high frequency steering12 0.25 (0.01) 0.25 (0.01) 0.25 (0.012) 0.25 (0.012) 0.25 (0.009) 0.24 (0.008) - 
Systolic blood pressure (mmHg) 122 (2.2) 117 (3.3) 120 (3.2) 120 (2.2) 124 (3) 119 (3.2) - 
Diastolic blood pressure (mmHg) 77 (1.7) 78 (2.8) 79 (3) 81 (1.9) 82 (2.9) 76 (2.7) 
 
- 
1 Visual Verbal Learning Test; 2 (number of words recalled at trial A3 – words recalled at A4) as a percentage of the number of words recalled at A3; 3 (number of words recalled at trial A1 – words recalled at B1) as 
a percentage of the number of words recalled at A1; 4 Visual Spatial Learning Test, 5 Rapid Visual Information Processing; 6 Coherence is a correlation between the speed cycle of the participant and the lead vehicle 
ranging from zero (no coherence between the two cycles) to one (perfect coherence); 7 Phase shift measures the delay between the change in the lead vehicle’s speed and the subsequent response by the participant. A 
lower score indicates better performance; 8 If the participant overreacts to the lead vehicle’s speed changes, the modulus will be larger than one; 9 Standard deviation of the lane position; 10 Exposure to imminent lane 
departure also known as time to line cross (TETtLC2); 11 Driving steering reversals (STREV was the number of changes in steering wheel direction per minute); 12 Driving high frequency steering (HFS) is a 
proportion of high frequency steering over all steering activity expressed in the frequency domain.   
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Figure Titles & Legends 
 
Figure 1 title : Immediate verbal recall (VVLT) averaged across trials A1-A3 for each 
condition and study phase (mean +/- se)  
Figure 1 legend: The Condition*Study Phase interaction for immediate verbal recall was 
significant (F[1,22]=5.58, p<0.05) . Post hoc tests revealed recall was better when the 
placebo was consumed at arm 2 relative to arm 1 (p<0.05), indicating an enduring effect of 
CGJ after cessation of treatment. Placebo arm 1 n=15, CGJ arm 1 n=14, placebo arm 2 n=10, 
CGJ arm 2 n=9. 
 
Figure 2 title: Tower of Hanoi completion time (seconds) for each condition and study phase 
(mean +/- se) 
Fig 2 legend: The Condition*Study Phase interaction was significant (F[1,21]=14.12, 
p<0.01). Post hoc tests revealed completion time was significantly faster for the CGJ (n=14) 
relative to the placebo at arm 1 (n=15) (p<0.01). This difference was not significant at arm 2. 
Placebo arm 1 n=15, CGJ arm 1 n=14, placebo arm 2 n=10, CGJ arm 2 n=9 
 
Figure 3 title: Steering reversals on the driving performance task for each condition and study 
phase (mean +/- se) 
Fig 3 legend: The Condition*Study Phase interaction was significant for steering reversals 
(F[1,10]=16.73, p<0.01) such that during arm 1 performance was better (fewer reversals) for 
the CGJ condition (n=8), whereas at arm 2 performance was better for the placebo condition 
(n=5). However, post hoc tests did not reach significance. Placebo arm 1 n=8, CGJ arm 1 
n=8, placebo arm 2 n=5, CGJ arm 2 n=5). 
 
